Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2004
11/10/2004CN1174979C Piperazine and piperidine compounds
11/10/2004CN1174978C Heterocyclic compound as inhibitors of rotamase enzymes
11/09/2004US6815440 For therapy and prophylaxis of disorders in the course of which is involved an increased activity of matrix-degrading metalloproteinases
11/04/2004WO2004094449A1 Macrolide-conjugates with anti-inflammatory activity
11/04/2004WO2004094413A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004WO2004094388A2 Indazole derivatives as jnk inhibitors
11/04/2004WO2004094386A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
11/04/2004WO2004093880A1 4-anilino-quinazoline derivatives as antiproliferative agents
11/04/2004WO2004093817A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/04/2004WO2004093789A2 Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/04/2004WO2004067506A3 Substituted heterocyclic compounds
11/04/2004WO2004062613A3 Hiv integrase inhibitors
11/04/2004WO2004061084A3 Modulation of protein functionalities
11/04/2004WO2004060865A3 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
11/04/2004WO2004056774A3 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
11/04/2004WO2004050681A3 Kinase modulators
11/04/2004WO2004004657A3 Hiv integrase inhibitors
11/04/2004WO2003087044A3 Novel carboxamide compounds for use in mch receptor related disorders
11/04/2004WO2003077847A3 Substituted amides
11/04/2004US20040220412 Compositions and kits pertaining to analyte determination
11/04/2004US20040220407 Process to prepare oxazolidinones
11/04/2004US20040220256 Formed as enantiomers of cis-beta-phenylglycidic acid/beta-phenylisoserine react with nitrile compound via ritter reaction
11/04/2004US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004US20040220243 optionally substituted thiazolyl, oxazolyl or pyrazolyl substituted heterocycles; use as pesticides and herbicides
11/04/2004US20040220238 Pyrrolidine oxadiazole-and thiadiazole derivatives
11/04/2004US20040220235 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
11/04/2004US20040220232 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone which is reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine; useful as p38 kinase and COX-2 inhibitors
11/04/2004US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004US20040220223 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
11/04/2004US20040220215 antidiabetic agents; insulin resistance; adjust glucose tolerance; anticholesterol agents; cardiovascular disorders; obesity; antiinflammatory agents
11/04/2004US20040220207 Chemokine receptor binding heterocyclic compounds
11/04/2004US20040220201 Tyrosine kinase inhibitors
11/04/2004US20040220196 antitumor agents; 4-amino-5-fluoro-3-(6-( 4-methylpiperazin-1-yl)1H-benzimidazol-2-yl)-quinolin-2-one
11/04/2004US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004US20040220191 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
11/04/2004US20040220183 inhibiting tumor necrosis factor; respiratory system disorders; prevent neutrophil infiltration in lungs; skin disorders
11/04/2004US20040220180 Compositions relating to novel compounds and targets thereof
11/04/2004US20040220177 Anticancer agents
11/04/2004US20040220174 for example, 1-(4-methoxyphenyl)-7-oxo-6-[5-(2-oxo-1-piperidinyl)2-pyridinyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; use as anticoagulant agent for treatment of thromboembolic disorders
11/04/2004US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide
11/04/2004US20040219686 Methods and mixtures pertaining to analyte determination
11/04/2004US20040219685 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation
11/04/2004CA2526897A1 4-anilino-quinazoline derivatives as antiproliferative agents
11/04/2004CA2522805A1 Phenacyl 2-hydroxy-3-diaminoalkanes
11/04/2004CA2522682A1 Indazole derivatives as jnk inhibitors
11/04/2004CA2518180A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b)
11/03/2004EP1472246A1 Oxadiazoles having antiproliferative activity
11/03/2004EP1472245A2 Heteroaryl compounds useful as inhibitors of gsk-3
11/03/2004EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004EP1472241A1 Cytoprotective benzofuran derivatives
11/03/2004EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004EP1472223A1 Gamma secretase inhibitors
11/03/2004EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004EP1471915A2 2,4-pyrimidinediamine compounds and their uses
11/03/2004EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004EP1421081A4 Method of mycophenolate mofetil preparation
11/03/2004EP1317425B1 Resorcinol derivatives
11/03/2004EP1232153B1 Imidazole derivatives and their use as raf kinase inhibitors
11/03/2004EP1189883B1 Substituted pyrrolidines as cell adhesion inhibitors
11/03/2004EP0942906B1 Compounds useful for inhibition of farnesyl protein transferase
11/03/2004CN1543460A Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
11/03/2004CN1543459A Quinoline derivatives and quinazoline derivatives having azolyl group
11/03/2004CN1543455A 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
11/03/2004CN1543346A Novel compounds
11/03/2004CN1543311A Selective substituted aryl ketone and safener based herbicides
11/03/2004CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
11/03/2004CN1173980C Organometallic complex molecule and organic electroluminescent device using the same
11/03/2004CN1173951C Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
11/02/2004US6812241 Nitrogen-containing heterocycles having parasiticidal properties
11/02/2004US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists
11/02/2004US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004US6812225 Pyschological disorders; antidepressants
11/02/2004CA2320676C Process and intermediates for the preparation of aminotriazine derivatives
11/02/2004CA2315614C Pyrazoles
11/02/2004CA2301787C New derivatives of benzo[3,4]cyclobuta[1,2-c]pyrrole, the procedure for preparing them and the pharmaceutical compounds that contain them
11/02/2004CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors
11/02/2004CA2282279C Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
11/02/2004CA2129040C Styryl derivatives and processes for their preparation
10/2004
10/28/2004WO2004092196A2 Tie-2 modulators and methods of use
10/28/2004WO2004092168A1 Cgrp receptor antagonists
10/28/2004WO2004092166A2 Cgrp receptor antagonists
10/28/2004WO2004092164A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
10/28/2004WO2004092145A1 Alpha substituted carboxylic acid as ppar modulators
10/28/2004WO2004092140A1 Biaryl substituted pyrazoles as sodium channel blockers
10/28/2004WO2004092135A2 Substituted benzosulphonamide as potentiators of glutamate receptors
10/28/2004WO2004092134A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004WO2004092132A1 [b]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/28/2004WO2004092131A1 Indole derivatives as ppar modulators
10/28/2004WO2004092130A2 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders
10/28/2004WO2004092124A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
10/28/2004WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004WO2004091613A2 Substituted phenyl acetamides and their use as protease inhibitors
10/28/2004WO2004091604A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004WO2004091518A2 Cxcr4 chemokine receptor binding compounds
10/28/2004WO2004091514A2 Cgrp receptor antagonists
10/28/2004WO2004091502A2 1,2,4-oxadiazole benzoic acid compounds
10/28/2004WO2004091485A2 Aminoquinoline compounds
10/28/2004WO2004080422A3 N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses